260 related articles for article (PubMed ID: 34402048)
1. Clinical characteristics of human platelet antigen (HPA)-1a and HPA-5b alloimmunised pregnancies and the association between platelet HPA-5b antibodies and symptomatic fetal neonatal alloimmune thrombocytopenia.
de Vos TW; Porcelijn L; Hofstede-van Egmond S; Pajkrt E; Oepkes D; Lopriore E; van der Schoot CE; Winkelhorst D; de Haas M
Br J Haematol; 2021 Nov; 195(4):595-603. PubMed ID: 34402048
[TBL] [Abstract][Full Text] [Related]
2. Anti-human platelet antigen-5b antibodies and fetal and neonatal alloimmune thrombocytopenia; incidental association or cause and effect?
Alm J; Duong Y; Wienzek-Lischka S; Cooper N; Santoso S; Sachs UJ; Kiefel V; Bein G
Br J Haematol; 2022 Jul; 198(1):14-23. PubMed ID: 35383895
[TBL] [Abstract][Full Text] [Related]
3. Fetal and Neonatal Alloimmune Thrombocytopenia-New Prospects for Fetal Risk Assessment of HPA-1a-Negative Pregnant Women.
Kjeldsen-Kragh J; Bengtsson J
Transfus Med Rev; 2020 Oct; 34(4):270-276. PubMed ID: 33039264
[TBL] [Abstract][Full Text] [Related]
4. Fetal and neonatal alloimmune thrombocytopenia: predictive factors of intracranial hemorrhage.
Delbos F; Bertrand G; Croisille L; Ansart-Pirenne H; Bierling P; Kaplan C
Transfusion; 2016 Jan; 56(1):59-66; quiz 58. PubMed ID: 26469867
[TBL] [Abstract][Full Text] [Related]
5. Natural history of human platelet antigen 1a-alloimmunised pregnancies: a prospective observational cohort study.
de Vos TW; Winkelhorst D; Porcelijn L; Beaufort M; Oldert G; van der Bom JG; Lopriore E; Oepkes D; de Haas M; van der Schoot E
Lancet Haematol; 2023 Dec; 10(12):e985-e993. PubMed ID: 38407610
[TBL] [Abstract][Full Text] [Related]
6. Maternal anti-platelet β3 integrins impair angiogenesis and cause intracranial hemorrhage.
Yougbaré I; Lang S; Yang H; Chen P; Zhao X; Tai WS; Zdravic D; Vadasz B; Li C; Piran S; Marshall A; Zhu G; Tiller H; Killie MK; Boyd S; Leong-Poi H; Wen XY; Skogen B; Adamson SL; Freedman J; Ni H
J Clin Invest; 2015 Apr; 125(4):1545-56. PubMed ID: 25774504
[TBL] [Abstract][Full Text] [Related]
7. Toward a prophylaxis against fetal and neonatal alloimmune thrombocytopenia: induction of antibody-mediated immune suppression and prevention of severe clinical complications in a murine model.
Tiller H; Killie MK; Chen P; Eksteen M; Husebekk A; Skogen B; Kjeldsen-Kragh J; Ni H
Transfusion; 2012 Jul; 52(7):1446-57. PubMed ID: 22251227
[TBL] [Abstract][Full Text] [Related]
8. Generation of human antibodies targeting human platelet antigen (HPA)-1a.
Oosterhoff JJ; Linty F; Visser R; de Vos T; Hofstede-van Egmond S; van de Weerd M; Porcelijn L; de Haas M; van der Schoot E; Vidarsson G
Transfusion; 2024 May; 64(5):893-905. PubMed ID: 38400657
[TBL] [Abstract][Full Text] [Related]
9. FNAIT pathogenesis determined by serial analysis of three subsequent pregnancies of a woman with severe fetal and neonatal alloimmune thrombocytopenia (FNAIT) with anti-HPA-4b and anti-HPA-5b alloantibodies in the first sibling.
Kiyokawa T; Mimura K; Nagamine K; Nakayama K; Horiuchi M; Morikawa T; Hosokawa M; Nakao M; Endo M; Kimura T; Kato H; Tomiyama Y; Kashiwagi H
Int J Hematol; 2023 Jul; 118(1):146-150. PubMed ID: 36797397
[TBL] [Abstract][Full Text] [Related]
10. Maternal HPA-1a antibody level and its role in predicting the severity of Fetal/Neonatal Alloimmune Thrombocytopenia: a systematic review.
Kjaer M; Bertrand G; Bakchoul T; Massey E; Baker JM; Lieberman L; Tanael S; Greinacher A; Murphy MF; Arnold DM; Baidya S; Bussel J; Hume H; Kaplan C; Oepkes D; Ryan G; Savoia H; Shehata N; Kjeldsen-Kragh J;
Vox Sang; 2019 Jan; 114(1):79-94. PubMed ID: 30565711
[TBL] [Abstract][Full Text] [Related]
11. Intracranial hemorrhages in neonates born from 32 weeks of gestation-low frequency of associated fetal and neonatal alloimmune thrombocytopenia: a register-based study.
Refsum E; Håkansson S; Mörtberg A; Wikman A; Westgren M
Transfusion; 2018 Jan; 58(1):223-231. PubMed ID: 29119564
[TBL] [Abstract][Full Text] [Related]
12. Marked thrombocytopenia in a neonate is associated with anti-HPA-5b, anti-HLA-A31, and anti-HLA-B55 antibodies.
Okubo M; Nishida E; Watanabe A; Nishizaki N; Obinata K; Azuma F; Matsuhashi M; Watanabe-Okochi N; Tsuno NH; Miyake K; Yamaguchi M; Yoshida K; Ohsaka A
Pediatr Blood Cancer; 2019 Mar; 66(3):e27555. PubMed ID: 30488611
[TBL] [Abstract][Full Text] [Related]
13. Maternal antibodies against paternal class I human leukocyte antigens are not associated with foetal and neonatal alloimmune thrombocytopenia.
Sachs UJ; Wienzek-Lischka S; Duong Y; Qiu D; Hinrichs W; Cooper N; Santoso S; Bayat B; Bein G
Br J Haematol; 2020 May; 189(4):751-759. PubMed ID: 31997312
[TBL] [Abstract][Full Text] [Related]
14. Current Anti-HPA-1a Standard Antibodies React with the β3 Integrin Subunit but not with αIIbβ3 and αvβ3 Complexes.
Bayat B; Traum A; Berghöfer H; Werth S; Zhu J; Bein G; Sachs UJ; Santoso S
Thromb Haemost; 2019 Nov; 119(11):1807-1815. PubMed ID: 31587244
[TBL] [Abstract][Full Text] [Related]
15. Platelet antibodies and fetal growth: maternal antibodies against fetal platelet antigen 1a are strongly associated with reduced birthweight in boys.
Tiller H; Killie MK; Husebekk A; Skogen B; Ni H; Kjeldsen-Kragh J; Øian P
Acta Obstet Gynecol Scand; 2012 Jan; 91(1):79-86. PubMed ID: 21895612
[TBL] [Abstract][Full Text] [Related]
16. HIP (HPA-screening in pregnancy) study: protocol of a nationwide, prospective and observational study to assess incidence and natural history of fetal/neonatal alloimmune thrombocytopenia and identifying pregnancies at risk.
Winkelhorst D; de Vos TW; Kamphuis MM; Porcelijn L; Lopriore E; Oepkes D; van der Schoot CE; de Haas M
BMJ Open; 2020 Jul; 10(7):e034071. PubMed ID: 32690731
[TBL] [Abstract][Full Text] [Related]
17. Towards a prophylactic treatment of HPA-related foetal and neonatal alloimmune thrombocytopenia.
Kjeldsen-Kragh J; Ni H; Skogen B
Curr Opin Hematol; 2012 Nov; 19(6):469-74. PubMed ID: 22954726
[TBL] [Abstract][Full Text] [Related]
18. Predicting risk severity and response of fetal neonatal alloimmune thrombocytopenia.
Salomon O; Rosenberg N
Br J Haematol; 2013 Aug; 162(3):304-12. PubMed ID: 23672281
[TBL] [Abstract][Full Text] [Related]
19. Postnatal treatment for children with fetal and neonatal alloimmune thrombocytopenia: a multicentre, retrospective, cohort study.
de Vos TW; Winkelhorst D; Árnadóttir V; van der Bom JG; Canals Surís C; Caram-Deelder C; Deschmann E; Haysom HE; Hverven HBC; Lozar Krivec J; McQuilten ZK; Muñiz-Diaz E; Nogués N; Oepkes D; Porcelijn L; van der Schoot CE; Saxonhouse M; Sola-Visner M; Tiblad E; Tiller H; Wood EM; Young V; Železnik M; de Haas M; Lopriore E
Lancet Haematol; 2022 Nov; 9(11):e844-e853. PubMed ID: 36108655
[TBL] [Abstract][Full Text] [Related]
20. Strategies to develop a prophylaxis for the prevention of HPA-1a immunization and fetal and neonatal alloimmune thrombocytopenia.
Kjær M; Geisen C; Akkök ÇA; Wikman A; Sachs U; Bussel JB; Nielsen K; Walles K; Curtis BR; Vidarsson G; Järås K; Skogen B
Transfus Apher Sci; 2020 Feb; 59(1):102712. PubMed ID: 31948915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
